Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated March 1, 2022, with respect to the consolidated financial statements of Recro Pharma, Inc. incorporated herein by reference.

/s/ KPMG LLP

Philadelphia, Pennsylvania

March 1, 2022